Human papillomavirus testing for primary cervical cancer screening: Is it time to abandon papanicolaou testing?

JAMA Internal Medicine

Volumn 174, Issue 10, 2014, Pages 1539-1540

  Feldman, Sarah ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER PREVENTION; CLINICAL PRACTICE; COLPOSCOPY; FEMALE; FOLLOW UP; HIV TEST; HUMAN; NOTE; PAPANICOLAOU TEST; RISK FACTOR; UTERINE CERVIX CANCER; WART VIRUS; ADULT; ALPHAPAPILLOMAVIRUS; CLINICAL TRIAL (TOPIC); COMPLICATION; EARLY DIAGNOSIS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; UTERINE CERVICAL NEOPLASMS; VIROLOGY; WORLD HEALTH ORGANIZATION;

ADULT; ALPHAPAPILLOMAVIRUS; CLINICAL TRIALS AS TOPIC; EARLY DETECTION OF CANCER; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 84908005744     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.4021     Document Type: Note

References (7)

1. National Cancer Institute. Cervical cancer. http://www.cancer.gov/cancertopics/types/cervical. Accessed July 1, 2014.
2. Roche Molecular Systems Inc. Medical Devices Advisory Committee Microbiology Panel Meeting: sponsor executive summary. http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/medicaldevices/medicaldevicesadvisorycommittee/microbiologydevicespanel/ucm388565.pdf. Accessed July 1, 2014.
3. Pollack A. FDA panel recommends replacement for the Pap test. New York Times. March 12, 2014. http://www.nytimes.com/2014/03/13/health/an-fda-panel-recommends-a-possible-replacement-for-the-pap-test.html. Accessed July 1, 2014.
4. Ronco G, Dillner J, Elfström KM, et al; International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383 (9916):524-532.
5. Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 2012;206(1): 46.e1-46.e11.
6. Feldman S. Can the new cervical screening and management guidelines be simplified? [published onlineMay 5, 2014]. JAMA Intern Med. doi:10.1001/jamainternmed.2014.576.
7. World Health Organization. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva, Switzerland: World Health Organization; 2013. http://www.who.int/reproductivehealth/topics/cancers/en/. Accessed July 1, 2014.